Roselabs Finance Limited has submitted a regulatory intimation to BSE Limited regarding an upcoming meeting of its Board of Directors. The meeting is scheduled to be held on Thursday, October 22, 2026.
The primary agenda of the board meeting is to consider and approve the un-audited financial results of the company for the quarter and half year ended September 30, 2026. The board will also review the limited review report for the same period.
The company had previously informed through a letter dated September 28, 2026, that the trading window for dealing in shares of the company has been closed for all designated persons in accordance with the Company's Code of Conduct for Prevention of Insider Trading. The trading window closure became effective from October 1, 2026, and will remain closed until 48 hours after the declaration of financial results by the company.
This intimation has also been uploaded on the company's website at www.roselabsfinancelimited.in.